← FDA Drug Approvals (Drugs@FDA)

REGROTON

NDA · New Drug Application · Sponsor: SANOFI AVENTIS US · Approved 1964-05-08

Drug application

FDA Application #
NDA015103
Application type
New Drug Application
Brand name
REGROTON
Generic name
Chlorthalidone
Active ingredients
CHLORTHALIDONE; RESERPINE
Dosage form
TABLET
Route
ORAL
Marketing status
Discontinued
Sponsor
SANOFI AVENTIS US
First approval
1964-05-08

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown